Diploma (LON:DPLM) Share Price Crosses Above Two Hundred Day Moving Average of $3,291.54

Shares of Diploma PLC (LON:DPLM) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 3,291.54 ($41.66) and traded as high as GBX 3,662 ($46.35). Diploma shares last traded at GBX 3,568 ($45.16), with a volume of 180,078 shares.

Analysts Set New Price Targets

DPLM has been the topic of a number of analyst reports. Berenberg Bank increased their price objective on shares of Diploma from GBX 3,800 ($48.10) to GBX 4,400 ($55.69) and gave the stock a “buy” rating in a report on Thursday, March 28th. Shore Capital reaffirmed a “buy” rating on shares of Diploma in a report on Wednesday, March 27th.

Diploma Stock Performance

The stock has a market cap of £4.78 billion, a price-to-earnings ratio of 3,964.44, a PEG ratio of 2.82 and a beta of 0.73. The company has a debt-to-equity ratio of 44.05, a quick ratio of 0.80 and a current ratio of 2.06. The company’s 50 day simple moving average is GBX 3,458.28 and its 200 day simple moving average is GBX 3,291.54.

Diploma Increases Dividend

The firm also recently disclosed a dividend, which was paid on Friday, February 2nd. Stockholders of record on Thursday, January 18th were paid a GBX 40 ($0.51) dividend. The ex-dividend date of this dividend was Thursday, January 18th. This represents a dividend yield of 1.32%. This is a boost from Diploma’s previous dividend of $16.50. Diploma’s payout ratio is currently 6,333.33%.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.